Risk Stratification and Management of Arterial Hypertension and Cardiovascular Adverse Events Related to Cancer Treatments: An Oncology Network from Piedmont and Aosta Valley (North-Western Italy) Consensus Document
Cancer patients receiving a potentially cardiotoxic oncologic therapy have an increased risk of cardiovascular adverse events (CVAEs), especially in presence of concomitant arterial hypertension (AH). Therefore, cancer patients should be evaluated before, during and after cardiotoxic treatments, to...
| Main Authors: | Giulia Mingrone, Elena Coletti Moia, Erica Delsignore, Gloria Demicheli, Paola Destefanis, Davide Forno, Giovanna Giglio Tos, Alessia Luciano, Giuliano Pinna, Laura Ravera, Antonella Fava, Franco Veglio, Oscar Bertetto, Alberto Milan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-01-01
|
| Series: | Hearts |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-3846/2/1/6 |
Similar Items
-
A comprehensive pediatric cardio-oncology program: a single institution approach to cardiovascular care for pediatric patients with cancer and childhood cancer survivors
by: Nathanya Baez Hernandez, et al.
Published: (2024-04-01) -
Current perspectives of cardio‐oncology: Epidemiology, adverse effects, pre‐treatment screening and prevention strategies
by: Jakub Bychowski, et al.
Published: (2023-07-01) -
Current Evidence on the Benefit of Exercise in Cancer Patients: Effects on Cardiovascular Mortality, Cardiotoxicity, and Quality of Life
by: Núria Coma, et al.
Published: (2023-06-01) -
Editorial: Cardio-oncology and reverse cardio-oncology: the manifold interconnections between heart failure and cancer
by: Alessandra Ghigo, et al.
Published: (2023-05-01) -
Cardio-oncology: the new frontier of clinical and preventive cardiology
by: Sara Paris, et al.
Published: (2020-06-01)